A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2007
11/22/2007	US20070269432 Method of Diagnosing Breast Cancer
11/22/2007	US20070269431 Protein Involved In Cancer
11/22/2007	US20070269430 Combination therapy for the treatment of acute leukemia and myelodysplastic syndrome
11/22/2007	US20070269429 Treatment with anti-erbb2 antibodies
11/22/2007	US20070269428 Method for the Treatment of Multiple Sclerosis by Inhibiting Il-17 Activity
11/22/2007	US20070269427 Therapeutical Use of Anti-Myelin Associated Glycoprotein (Mag) Antibodies
11/22/2007	US20070269426 Use of Soluble Gammadelta Cell Receptors for Regulating T Cell Function
11/22/2007	US20070269425 Anti-Idiotype Antibodies of the Human Monoclonal Antibody Sc-1, and Their Production and Use
11/22/2007	US20070269424 Moraxella bovis cytotoxin, cytotoxin gene, antibodies and vaccines for prevention and treatment of moraxella bovis infections
11/22/2007	US20070269423 kit comprises a nucleic acid, use for detection and treatment of human cancers by inhibiting the enzyme activities; biodrug as anticarcinogenic agents
11/22/2007	US20070269422 Serum albumin binding proteins with long half-lives
11/22/2007	US20070269421 Diagnostics and Therapeutics for Diseases Associated with Plasma Glutamate Carboxypeptidase (Pgcp)
11/22/2007	US20070269420 Compounds, Compositions and Methods for Treatment and Prophylaxis of Hepatitis C Viral Infections and Associated Diseases
11/22/2007	US20070269419 Use of Caspase-8 Inhibitors for Modulating Hematopoiesis
11/22/2007	US20070269416 Live bacteria product
11/22/2007	US20070269409 Adenoviral Vector Vaccine
11/22/2007	US20070269408 GENES OF IL-12p40 SUBUNIT MUTATED FOR IMPROVING THE ACTIVITY OF IL-12 AND USE THEREOF FOR DNA VACCINE ADJUVANT
11/22/2007	US20070269406 Transcatheter tumor immunoembolization
11/22/2007	US20070269385 Devices, methods, and systems for delivering therapeutic agents for the treatment of sinusitis, rhinitis, and other disorders
11/22/2007	US20070269377 Method of Producing Partial Peptide of Enolase Protein from Plasmodium Falciparum
11/22/2007	US20070269376 Method for Determining Dosage for an Oral Killed Vaccine
11/22/2007	US20070269372 monoclonal antibodies or fragment thereof which binds a cell surface glycoprotein antigen located on the surface of human multiple myeloma tumor cells; for therapeutic, screening, diagnostic and cell purification purposes
11/22/2007	US20070269371 Antibodies with altered effector functions
11/22/2007	US20070269370 Compositions and methods for treating B-cell malignancies
11/22/2007	CA2652452A1 Neutralizing antibodies to influenza viruses
11/22/2007	CA2652274A1 Il-1.alpha. immunization induces autoantibodies protective against atherosclerosis
11/22/2007	CA2652103A1 Anthrax vaccine
11/22/2007	CA2651883A1 Method and means for treating inflammatory bowel disease
11/22/2007	CA2651419A1 Diagnostic methods for determining treatment
11/22/2007	CA2651067A1 Combination therapy product and uses thereof
11/22/2007	CA2650455A1 Real-time detection of influenza virus
11/22/2007	CA2650237A1 Nicotine-carrier vaccine formulation
11/22/2007	CA2647102A1 Ras mutation and compositions and methods related thereto
11/22/2007	CA2633439A1 Methods of treating pain and inflammation in neuronal tissue using il-31ra and osmrb antagonists
11/21/2007	EP1857554A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007	EP1857553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007	EP1857546A1 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
11/21/2007	EP1857464A2 Chlamydia antigens
11/21/2007	EP1857122A2 Pharmaceutical compound, containing a stabilised mRNA which is optimised for translation in its coded areas
11/21/2007	EP1857121A2 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
11/21/2007	EP1857117A1 Agent for stimulating the production of a blood coagulation factor viii
11/21/2007	EP1857116A1 Antigen binding polypeptides against spike glycoprotein (S2) of bovine coronavirus
11/21/2007	EP1857115A2 Using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
11/21/2007	EP1857113A2 Method and materials for treating asthma
11/21/2007	EP1856539A2 Methods of predicting therpeutic response in atopic dermatitis to il-31 antagonists
11/21/2007	EP1856531A2 Method for diagnosing multiple sclerosis
11/21/2007	EP1856271A2 Influenza hemagglutinin and neuraminidase variants
11/21/2007	EP1856240A2 Influenza virus harvester
11/21/2007	EP1856155A2 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor
11/21/2007	EP1856154A1 Humanized anti-ghrelin antibodies
11/21/2007	EP1856153A1 Ykl-40 monoclonal antibodies
11/21/2007	EP1856149A2 Cxcr3 is a gliadin receptor
11/21/2007	EP1856143A2 Hivcon: anhiv immunogen and uses thereof
11/21/2007	EP1856141A1 N protein mutants of porcine reproductive and respiratory syndrome virus
11/21/2007	EP1855720A1 Use of a modified proxvirus for the rapid induction of immunity against a poxvirus or other infectious agents
11/21/2007	EP1855719A2 Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus
11/21/2007	EP1855718A2 Adhesin as immunogen against escherichia coli
11/21/2007	EP1855717A1 Surface-located streptococcus pneumoniae polypeptides
11/21/2007	EP1855716A2 Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis
11/21/2007	EP1855715A2 Gna1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
11/21/2007	EP1855714A2 Methods for reducing the symptoms of autoimmunity and inflammation using binding proteins against antigens exposed on dead or dying cells
11/21/2007	EP1855713A2 Genetically engineered equine influenza virus and uses thereof
11/21/2007	EP1855710A1 Muscle regeneration
11/21/2007	EP1855709A1 Use of myostatin (gdf-8) antagonists for improving wound healing and preventif fibrotic disease
11/21/2007	EP1855595A2 Pharmaceutical liposomal compositions
11/21/2007	EP1414492B1 Method for treating multiple myeloma
11/21/2007	EP1269196B1 Method of screening for inhibitors of osteopontin
11/21/2007	EP1200459B1 Compounds for treatment of infectious and immune system disorders and methods for their use
11/21/2007	EP1019087B1 Ganglioside immunostimulating complexes and uses thereof
11/21/2007	EP0904378B1 Hepatitis b monoclonal antibodies
11/21/2007	EP0522091B9 Use of a mbp peptide for the preparation of a medicament for the treatment of multiple sclerosis
11/21/2007	CN101076591A Novel human virus causing respiratory tract infection and uses thereof
11/21/2007	CN101076543A Single domain camelide anti-amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenerative neural diseases such as alzheimer's disease
11/21/2007	CN101076542A Antibodies specific for hepatocellular carcinoma and other carcinomas and uses thereof
11/21/2007	CN101076371A Novel pharmaceutical composition containing at least one dolastatin 10 derivative
11/21/2007	CN101076356A Electroporation of mycobacterium and overexpression of antigens in mycobacteria
11/21/2007	CN101076355A Influenza vaccination
11/21/2007	CN101076353A Releasable polymer conjugate based on aliphatic biodegradable joint
11/21/2007	CN101076352A Il-15 antigen array and its application
11/21/2007	CN101076351A Cytokine-expressing cellular vaccines for treatment of prostate cancer
11/21/2007	CN101076346A Lactic acid bacteria and its application in preventing diarrhea
11/21/2007	CN101074442A Recombinant expression and use for pertussis vaccine protective antigen
11/21/2007	CN101074261A TRAIL receptor I and/or TRAIL receptor 2 specific antibody and its use
11/21/2007	CN101074260A Production of hygrophilous monospermous bacterium main-protective antigen univalent and multivalent vitelline antibody and use in aquatic animal
11/21/2007	CN101073668A Antibody compositions for selectively inhibiting vegf
11/21/2007	CN101073667A Enhancer for antibody to lymphocytic tumors
11/21/2007	CN100350048C Recombinant bacillus Calmette-Guerin vaccine and its preparation method
11/21/2007	CN100350040C Cell separation compositions methods
11/21/2007	CN100349920C Ganalioside-associated recombinant antibodies and use thereof in diagnosis and treatment of tumours
11/21/2007	CN100349919C Monoclonal antibody and its preparing process and usage
11/21/2007	CN100349632C Microprojection array having beneficial agent contg coating
11/21/2007	CN100349562C Ophthalmic drug delivery device
11/20/2007	US7297784 Genetic enhancers comprising amino acid sequences derived from retrovirus envelope proteins coupled to core peptides, used as drugs having improve half life
11/20/2007	US7297783 Hsp60 from arthrobacter
11/20/2007	US7297764 PRO4318 polypeptides
11/20/2007	US7297537 Genome sequences and nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences, and cells transformed by the vectors; kits for diagnosing infection and vaccines
11/20/2007	US7297533 Two types of foreign genes inserted in such a manner as to allow the expression into two different regions in the recombinant feline herpesvirus type 1 genome
11/20/2007	US7297488 Identifying and testing antisense oligonucleotides that inhibit telomerase reverse transcriptase
11/20/2007	US7297341 Chlamydia antigens and corresponding DNA fragments and uses thereof
11/20/2007	US7297340 containing a biofilm peptide, especially a Haemophilus influenzae biofilm peptide, used to prevent otitis media

1 ... 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 ... 1823